Trexquant Investment’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-50,336
| Closed | -$250K | – | 1428 |
|
2023
Q2 | $250K | Sell |
50,336
-36,924
| -42% | -$184K | 0.01% | 1245 |
|
2023
Q1 | $431K | Sell |
87,260
-24,625
| -22% | -$122K | 0.01% | 1058 |
|
2022
Q4 | $704K | Buy |
+111,885
| New | +$704K | 0.02% | 778 |
|
2022
Q3 | – | Sell |
-14,853
| Closed | -$169K | – | 1326 |
|
2022
Q2 | $169K | Buy |
+14,853
| New | +$169K | 0.01% | 1388 |
|
2021
Q3 | – | Sell |
-24,321
| Closed | -$634K | – | 1101 |
|
2021
Q2 | $634K | Buy |
+24,321
| New | +$634K | 0.05% | 416 |
|
2020
Q4 | – | Sell |
-11,207
| Closed | -$423K | – | 989 |
|
2020
Q3 | $423K | Sell |
11,207
-4,073
| -27% | -$154K | 0.03% | 768 |
|
2020
Q2 | $654K | Sell |
15,280
-12,201
| -44% | -$522K | 0.05% | 564 |
|
2020
Q1 | $534K | Buy |
27,481
+13,421
| +95% | +$261K | 0.04% | 631 |
|
2019
Q4 | $365K | Buy |
+14,060
| New | +$365K | 0.02% | 670 |
|